Suchergebnisse - "Norton, Elizabeth B."

PubPharm (5)

1

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model

enthalten in: Microbiology spectrum | 2024

von Patel, D. | Minns, A. | Sim, D. | +11

UpdateOf: bioRxiv. 2022 Dec 14;:. - PMID 36324809

2

An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines

enthalten in: PLoS pathogens | 2022

von Seifert, S. | Bai, S. | Fawcett, S. | +5

3

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial

enthalten in: Vaccine | 2022

von Crothers, J. | Ross Colgate, E. | Cowan, K. | +6

ErratumIn: Vaccine. 2022 May 31;40(25):3481. - PMID 35534312

4

The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model

enthalten in: Vaccine | 2015

von Norton, E. | Bauer, D. | Weldon, W. | +3

5

Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

enthalten in: Human vaccines & immunotherapeutics | 2014

von White, J. | Blum, J. | Hosken, N. | +10

1
[1]